The Number of ICOBox's Clients Quadrupled in 2018
December 28, 2018 20:40 ET
|
ICOBox
George Town, Cayman Islands, Dec. 28, 2018 (GLOBE NEWSWIRE) -- In Q3 and Q4 2018 ICOBox helped 15 projects collect more than $45 million via their ICOs. Some of these token sales are still ongoing,...
Flex LNG Ltd. Interim Financial Information, Third Quarter 2018
November 27, 2018 00:01 ET
|
FLEX LNG
HAMILTON, Bermuda, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Flex LNG Ltd. (Oslo Børs: FLNG) (together with its subsidiaries, the “Company” or “Flex LNG”), an emerging leader in the Liquefied Natural Gas...
VitalHub Continues to Report Positive Adjusted EBITDA Results and Increased Revenues
November 26, 2018 15:16 ET
|
Vitalhub Corp.
TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and...
ALM Equity AB (publ): Delårsrapport januari-september 2018
November 22, 2018 10:17 ET
|
ALM Equity AB
Stockholm, 2018-11-22 JANUARI – SEPTEMBER 2018 Enligt segmentsredovisningen* uppgick omsättningen till 1 599,2 (1 922,9) Mkr och rörelseresultatet till 131,8 (267,1) Mkr. Resultat efter skatt...
Weyland Tech Inc. Updates Shareholders on Its Q3 Results and Business Outlook
November 16, 2018 10:37 ET
|
Weyland Tech, Inc.
New York, NY, Nov. 16, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Weyland Tech Inc. (WEYL) ("Weyland " or the "Company"), a provider of mobile business applications, today updates shareholders on...
Equillium Reports Third Quarter 2018 Financial Results and Recent Highlights
November 15, 2018 16:07 ET
|
Equillium, Inc.
Completes Successful Initial Public Offering Raising Gross Proceeds of Approximately $71.6 Million On-Track for Early 2019 Initiation of Phase 1b/2 Trial of EQ001 in Acute Graft-Versus-Host Disease ...
Infant Bacterial Therapeutics AB (publ), (IBT) Delårsrapport 1 januari – 30 september 2018
November 14, 2018 02:00 ET
|
Infant Bacterial Therapeutics AB
VD kommenterar Arbete med att förbereda den planerade fas III – studien, kallad ”The Connection Study” fortskrider. Förutom att vi fått igång vår CRO (Premier Research) har vi förstärkt vår egen...
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2018
November 14, 2018 02:00 ET
|
Infant Bacterial Therapeutics AB
Message from the CEO The third quarter was dominated by extensive preparatory work relating to the planned phase III study, called “The Connection Study”. In addition to chosing the CRO (Premier...
SilverSun Technologies Reports Profitable Third Quarter 2018 Results
November 13, 2018 11:52 ET
|
SilverSun Technologies, Inc.
Company Posts Best Quarterly Revenue in Corporate History EAST HANOVER, NJ, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SilverSun Technologies, Inc. (NASDAQ: SSNT), a national...
VBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate Update
November 09, 2018 07:00 ET
|
VBI Vaccines, Inc.
-- Completion of vaccination and enrollment in Sci-B-Vac® PROTECT and CONSTANT Phase 3 studies, respectively -- -- Encouraging early immunologic data observed in Phase 1/2a study of...